Bluejay Diagnostics (BJDX) Cash from Investing Activities (2021 - 2026)
Bluejay Diagnostics' (BJDX) quarterly Cash from Investing Activities came in at -$15314.0 in Q1 2026, down 1261.24% quarter-over-quarter from -$1125.0 in Q4 2024.
Bluejay Diagnostics (BJDX) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Bluejay Diagnostics has disclosed Cash from Investing Activities across 5 years of filings, most recently posting -$15314.0 for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$15314.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$286664.0 (changed N/A YoY), and the FY2025 annual result was -$173735.0, up 43.37% from the prior year.
- Cash from Investing Activities came in at -$15314.0 for Q1 2026 at Bluejay Diagnostics, down from -$1125.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$227.0 in Q3 2024 to a low of -$791464.0 in Q3 2022.
- The 4-year median for Cash from Investing Activities is -$87894.0 (2023), against an average of -$171194.8.
- Across the five-year window, Cash from Investing Activities tumbled 18392.15% in 2022 and surged 99.7% in 2024, its largest moves.
- Bluejay Diagnostics' Cash from Investing Activities stood at -$238207.0 in 2022, then jumped by 63.1% to -$87894.0 in 2023, then surged by 98.72% to -$1125.0 in 2024, then slumped by 1261.24% to -$15314.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$15314.0 (Q1 2026), -$1125.0 (Q4 2024), and -$227.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Bluejay Diagnostics | 4.43 Mn | 746,549.00 | - | -15,314.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,314.00 |
| Mar 31, 2026 | -15,314.00 |
| Dec 31, 2024 | -1,125.00 |
| Dec 31, 2024 | -1,125.00 |
| Sep 30, 2024 | -227.00 |
| Sep 30, 2024 | -227.00 |
| Jun 30, 2024 | -269,998.00 |
| Jun 30, 2024 | -269,998.00 |
| Mar 31, 2024 | -35,433.00 |
| Mar 31, 2024 | -35,433.00 |
| Dec 31, 2023 | -87,894.00 |
| Dec 31, 2023 | -87,894.00 |
| Sep 30, 2023 | -74,498.00 |
| Sep 30, 2023 | -74,498.00 |
| Jun 30, 2023 | -201,105.00 |
| Jun 30, 2023 | -201,105.00 |
| Mar 31, 2023 | -340,669.00 |
| Mar 31, 2023 | -340,669.00 |
| Dec 31, 2022 | -238,207.00 |
| Dec 31, 2022 | -238,207.00 |